当前位置: 首页 > 期刊 > 《现代医药卫生》 > 2008年第22期
编号:11702470
慢性乙型肝炎患者血清TGF-β1水平与肝纤维化的关系(2)
http://www.100md.com 2008年11月15日 《现代医药卫生》 2008年第22期
     参考文献:

    [1] 黄耀煊.肝病分子生物学[M].福州:福建科学技术出版社,2003.254.

    [2] 中华医学会传染病与寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(10):324.

    [3] Gressner AM,Weiskirchen R,Breitkopf K,et al. Roles of TGF-β in hepatic fibrosis[J].Front Biosci,2002,7:793.

    [4] Corpechot C,Barbu V,Wendum D,et al. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia:a potential mechanism for liver regeneration failure in experimental cirrhosis[J].Am J Pathol,2002,160(2):613.

    [5] Uria JA,Jimenez MG,Balbin M,et al. Differential effects of growth factorβ on the expression of collagenase-Ⅰand collagenase-Ⅲin hu-man fibroblasts[J]. J Biol Chem,1998,273(16):9769.

    [6] Yuan W,Varga J. Transforming growth factorBrepression of matrix metalloproteinase-I in dermal fibroblasts involves smad -3[J]. J Biol Chem,2001,276(42):38502.

    [7] Flisiak R,Maxwell P,Prokopowicz D,et al. Plasma tissue in hibitor of metalloproteinases-1 and transforminggrowth factor β1-possible non-invasive biomarkers of hepatic fibrosis in patientswith chronic B and C hepatitis [J].Hepatogastroenterology, 2002,49(47):1369.

    [8] 李兵顺,阎文昭.肝组织与血清转化生长因子B1水平与病毒性肝炎患者肝纤维化的关系[J].中华肝脏病杂志,2004,12(5):271.

    收稿日期:2008-06-24, 百拇医药(覃后继 覃雪英 周耀南 何延专)
上一页1 2